| GDM | Not GDM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Treatment Group | Routine Care Group | Control Group | |||||||||
 | BW* | BW+BMI* | BW* | BW+BMI* | BW* | BW+BMI* | ||||||
Plasma Glucose (mmol/ml) | 4.7 | 0.2 | 4.7 | 0.2 | 4.8 | 0.2+ | 4.9 | 0.2+ | 4.3 | 0.2 | 4.3 | 0.2 |
Serum Insulin (μU/ml)^ | 2.0 | 0.2 | 2.1 | 0.2 | 2.1 | 0.2 | 2.1 | 0.2 | 2.0 | 0.1 | 2.0 | 0.1 |
Insulin to Glucose Ratio^ | 0.6 | 0.2 | 0.6 | 0.2 | 0.6 | 0.2 | 0.5 | 0.2 | 0.6 | 0.1 | 0.5 | 0.1 |
Serum Adiponectin (ng/ml) | 22.1 | 2.2+ | 21.4 | 2.2+ | 23.0 | 2.0+ | 23.6 | 2.1+ | 27.0 | 1.7 | 27.8 | 1.8 |
Serum Leptin (ng/ml)^ | 2.4 | 0.1 | 2.4 | 0.1 | 2.5 | 0.1 | 2.5 | 0.1 | 2.4 | 0.1 | 2.5 | 0.1 |
Adiponectin to Leptin Ratio^ | 0.7 | 0.2 | 0.6 | 0.2 | 0.6 | 0.2 | 0.6 | 0.2 | 0.8 | 0.1 | 0.8 | 0.1 |